Dimethyl fumarate (BG-12) first line oral treatment for people with multiple sclerosis | Cochrane

Dimethyl fumarate was approved by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency for adults with relapsing-remitting multiple sclerosis (RRMS). It does not require that any other medication be tried before dimethyl fumarate is prescribed. Although data from non Coch...